阿片类受体揭示了内体G蛋白激活的离散细胞机制
Nicole M Fisher1,2, Mark von Zastrow1,2,3
1Department of Psychiatry and Behavioral Sciences, University of California, San Francisco, San Francisco, CA, USA.
bioRxiv : the preprint server for biology
|October 17, 2024
概括
μ-阿片类受体 (MOR) 增加了G蛋白在内分体上的活性,这与之前认为的不同. 这种G蛋白结合受体 (GPCR) 机制涉及G蛋白贩运,而不是受体内化,以提高信号传输.
科学领域:
- 细胞生物学 细胞生物学
- 分子药理学分子药理学
- 神经科学是一个神经科学.
背景情况:
- G蛋白结合受体 (GPCRs) 信号来自内体,需要增加G蛋白活性.
- 据信,Gs结合的GPCR在内部化后会在内分体上重新激活G蛋白.
研究的目的:
- 为了研究μ-阿片类受体 (MOR) 的机制,一个Gi-合的GPCR,增加内体G蛋白活性.
- 为了区分MOR信号与已建立的Gs-合的GPCR范式.
主要方法:
- 利用形态生物传感器来跟踪亚细胞激活动态.
- 检查了内源表达的MOR和Gi/o-G子类蛋白质.
- 研究了MOR内化和内体激活的作用.
主要成果:
- MOR激活会导致血膜上活性Gi/o的暂时增加.
- 在MOR激活后,内体上发生了长时间的活性Gi/o的增加.
- 由MOR激活内体Gi/o不需要MOR内化或内体受体激活.
结论:
- 提出了一种新的GPCR介导的内体G蛋白活性升高的机制.
- 这种机制依赖于受管制的激活G蛋白的贩运,与激活GPCR的G蛋白不同.
- 突出了像MOR.这样的Gi结合的GPCRs独特的信号通路.
相关概念视频
Opioid Receptors: Overview
555
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
555
GPCR Desensitization
5.9K
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
5.9K
Transducer Mechanism: G Protein–Coupled Receptors
1.9K
G Protein–Coupled Receptors (GPCRs) are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to various stimuli. GPCRs regulate critical physiological pathways and are excellent drug targets for treating diseases such as diabetes, cancer, obesity, depression, or Alzheimer's. Nearly 35% of approved drugs implement their therapeutic effects by selectively interacting with specific GPCRs.
GPCRs are also called heptahelical,...
GPCRs are also called heptahelical,...
1.9K
Analgesia and Pain Management
540
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
540
GPCRs Regulate Adenylyl Cylase Activity
5.3K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
5.3K
Activation and Inactivation of G Proteins
6.8K
Heterotrimeric G proteins are guanine nucleotide-binding proteins. As the name suggests, heterotrimeric G proteins are composed of three subunits: alpha, beta, and gamma. They remain GDP-bound or GTP-bound inside the cells and switch between inactive/active states. The Gα subunit possesses the nucleotide-binding pocket that binds guanine nucleotides and switches between GDP or GTP-bound states. In contrast, the Gꞵ and Gγ subunits are always bound together with high...
6.8K


